Analyst Research

Report Title Price
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Recordati Industria Chimica E Farmaceutica SpA Updates FY 2013 Guidance; Resolves FY 2013 Interim Dividend Distribution


Wednesday, 30 Oct 2013 08:04am EDT 

Recordati Industria Chimica E Farmaceutica SpA announced that it has updated its full fiscal year 2013 targets. For the full fiscal year 2013, targets are to achieve sales of more than EUR 930 million, operating income of more than EUR 190 million and net income of more than EUR 132 million. According to I/B/E/S Estimates, analysts on average are expecting the Company to report for fiscal year 2013 revenues of EUR 938.32 million, EBIT of EUR 194.23 million and net income of EUR 133.30 million. Recordati Industria Chimica E Farmaceutica SpA also announced that the Board of Directors resolved to distribute an interim dividend relating to the fiscal year 2013 amounting to EUR 0.22 (before withholding tax) on each outstanding share, excluding shares in treasury stock. The interim dividend will be paid, through the authorized intermediaries, as from November 21, 2013 on coupon No. 12 to be presented on November 18, 2013. 

Company Quote